Initial Testing of the Aurora Kinase A Inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)

Lignende værker

• Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer
  af: Carol, Hernan, et al.
  Udgivet: (2011)
• Initial Testing of the Investigational NEDD8 Activating Enzyme Inhibitor MLN4924 by the Pediatric Preclinical Testing Program
  af: Smith, Malcolm A., et al.
  Udgivet: (2011)
• Initial Testing (Stage 1) of the Investigational mTOR Kinase Inhibitor MLN0128 by the Pediatric Preclinical Testing Program
  af: Kang, Min H., et al.
  Udgivet: (2014)
• Initial Testing (Stage 1) of Vorinostat (SAHA) by the Pediatric Preclinical Testing Program
  af: Keshelava, Nino, et al.
  Udgivet: (2009)
• Initial Testing (Stage 1) of Temozolomide by the Pediatric Preclinical Testing Program
  af: Keir, Stephen T., et al.
  Udgivet: (2013)